Zimmer Biomet Q3 FY26: where the revenue came from and where it went
The whole income statement of Zimmer Biomet for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2026
- Reported
- Nov 4, 2026
Revenue$2.06B
+3% year over year
Gross profit$1.47B
71% margin
Operating profit$0.31B
15% margin
Net profit$0.19B
9% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 2.06 | 100% | +3% |
| Knees | 0.77 | 37% | −3% |
| SET | 0.58 | 28% | +7% |
| Hips | 0.54 | 26% | +6% |
| Technology & data bone | 0.18 | 9% | +12% |
| Cost of revenue | −0.60 | 29% | |
| Gross profit | 1.47 | 71% margin | −1pp |
| SG&A | −0.86 | 41% | +1pp |
| Other | −0.31 | 15% | +0pp |
| Operating profit | 0.31 | 15% margin | −3pp |
| Interest & other costs | −0.08 | ||
| Tax | −0.04 | ||
| Net profit | 0.19 | 9% margin | −2pp |
22 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest